Neuropathic Pain Management

Medication Guidelines

Gabapentin should be initiated at 100-300 mg at bedtime or 100-300 mg three times daily, then gradually increased by 100-300 mg every 1-7 days as tolerated, targeting a total daily dose of 900-3600 mg divided into three doses, as recommended by the American Academy of Neurology 1
The target dose of gabapentin is 300-1200 mg three times daily, with a total daily dose of 900-3600 mg, and a duration of adequate trial for gabapentin is 3-8 weeks for titration plus 2 weeks at maximum dose 1
Gabapentin dosing guidelines for patients with renal impairment are as follows:

Pregabalin is preferred over gabapentin for neuropathic pain due to its more predictable pharmacokinetics, with an effective starting dose of 150 mg/day, as recommended by the Mayo Clinic Proceedings 1
Duloxetine has demonstrated efficacy for diabetic peripheral neuropathic pain, with 60 mg once daily being the recommended dose, as suggested by the American Diabetes Association 1, 4
Capsaicin 8% dermal patch or cream is highly recommended for peripheral neuropathic pain, with a single 30-minute application providing pain relief for up to 12 weeks, and is recommended for HIV-associated peripheral neuropathic pain 5
Topical lidocaine is effective for localized peripheral neuropathic pain, according to the Mayo Clinic Proceedings 1

Hypnosis is recommended for neuropathic pain (strong recommendation) 5
Cognitive behavioral therapy (CBT) is strongly recommended for chronic pain management 5
Physical and occupational therapy are recommended (strong, low-quality evidence) 5
Acupuncture may be considered as a complementary therapy for neuropathic pain, according to the American Society of Clinical Oncology 6
Behavioral interventions, such as breathing exercises, relaxation techniques, imagery or hypnosis, and cognitive behavioral therapy, are effective for enhancing pain control and reducing reliance on medications, as recommended by the American Psychological Association 7

HIV patients should use alpha lipoic acid and avoid lamotrigine, as recommended by the Clinical Infectious Diseases guidelines 5
Diabetic patients should optimize glycemic control in addition to pain management, as recommended by the American Diabetes Association 8
Women of reproductive potential should receive counseling regarding reliable contraception methods, as gabapentin is not recommended for women who are pregnant, actively trying to conceive, or nursing, as recommended by the American College of Physicians 9
Elderly patients should start with lower doses and titrate more slowly, monitoring closely for cognitive impairment and sedation, with TCAs started at 10 mg/day and avoided at doses >75 mg/day, as recommended by the American College of Physicians 4, 3

Pain and health-related quality of life should be reassessed frequently, and if substantial pain relief is achieved, treatment should be continued, as recommended by the American College of Physicians 1
If partial pain relief is achieved after an adequate trial, consider adding another first-line medication, according to the American College of Physicians 1
Monitoring for excessive sedation is crucial, as it may precede respiratory depression, as recommended by the American College of Physicians 10
Naloxone should be considered for patients receiving ≥50 morphine milligram equivalents or when combining with gabapentin, as recommended by the American College of Physicians 10
Referral to a neurologist or pain specialist is recommended when pain control is not achieved with initial therapies, diagnosis is unclear or clinical features are atypical, or complex medication regimens are needed, as recommended by the American College of Physicians and the American Academy of Neurology 11, 12, 13